Navigation Links
SNM praises CMS decision to expand reimbursement for cancer treatment
Date:1/9/2009

Reston, Va.On Jan. 6, the Centers for Medicare and Medicaid Services (CMS) released a draft of their proposed positron emission tomography (PET) national coverage determination (NCD). This proposed legislation would allow for reimbursement of PET by the federal government for patients with all types of cancer. The proposed decision expands coverage to include cancer staging and restaging, in addition to initial diagnosis. Two important items in the CMS draft include a proposal to replace coverage for "diagnosis, staging and restaging and treatment" with "initial treatment" and "subsequent treatment." A public comment period on these and other items will continue through Feb. 5. A final decision is expected in April 2009.

In concert with other nonprofit medical associations, SNM has worked closely with CMS over the past three years to increase access to these medically essential molecular imaging procedures used for the diagnosis, staging and restaging of cancer. Molecular imaging provides a rich portrait of exactly what is going on in a patient's body, offering a wealth of useful information to help shape a treatment plan.

"We are highly encouraged by the CMS proposal to broaden reimbursement for PET for Medicare beneficiaries who are being treated for cancer," said SNM President Robert W. Atcher, Ph.D., M.B.A. "Because PET is a minimally invasive imaging procedure that gives physicians critical information for patient care, expanded use of the technique in cancer diagnosis and treatment will help tailor the patient's treatment to their current stage of the disease."

In 2006, a nationwide studythe National Oncologic PET Registry (NOPR)was established to collect data in response to a proposal from CMS to expand coverage for PET to include cancers and indications not presently eligible for Medicare reimbursement. Overwhelmingly, the data collected showed that PET has significant advantages for diagnosing, staging and restaging many types of cancer. According to a study published last year in The Journal of Clinical Oncology, PET resulted in a change in management of treatment in more than one-third of cancer patients, regardless of the type of cancer.

"This is a critical step in gaining access to critical molecular imaging and nuclear medicine tests for people nationwide with all forms of cancer," added Atcher.


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. AHIP Praises Bipartisan Senate Vote on Mental Health Parity
2. Union President Praises Hillary Clintons Health Plan
3. AIDS Action Council Praises Release of Latest State of AIDS in Black America Report
4. Lung Cancer Alliance Praises Congressional Call for Increased Commitment to Fund Lung Cancer Research
5. Bishops Conference Praises Senate Introduction of Pregnant Women Support Act
6. American Life League Praises Colorado Efforts to Stop Planned Parenthood Abortion Facility
7. Alliance for Quality Nursing Home Care Praises CMS Release of Updated Special Focus Facilities (SFF) List
8. Blunt Praises Presidents Plan to Save Medicare
9. FRC Action Praises John McCains Pro-Life Comments
10. Consumer Watchdog Praises CA HMO Regulators Promise to Reinstate Health Coverage for Wrongfully Cancelled Patients; Cautions That All Health Costs During Gap Must be Covered
11. USCCB Official Praises Senate Passage of Genetic Information Nondiscrimination Act
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... , ... Discover the Rocky Mountain region’s longest running and impressive garden and ... also get to see the most incredible gardens and home improvement experts that attend ... Colorado Convention Center - 700 14th St. Denver CO, is an exciting event that ...
(Date:2/8/2016)... Nevada (PRWEB) , ... February 08, 2016 , ... ... RowdMap, Inc., will be speaking on how healthcare companies can use newly released ... manage the health of a population and intervene and capture the value they ...
(Date:2/7/2016)... , ... February 07, 2016 , ... ... with the latest techniques and the most minimally invasive approaches. , Women who ... particularly after menopause. Other risk factors include surgery to the pelvic floor, connective ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... NURSES EXPECTED AT AORN SURGICAL CONFERENCE & EXPO , WHAT:     , This ... an estimated 5000 perioperative nurses in attendance to study the latest evidence-based ...
(Date:2/6/2016)... ... February 06, 2016 , ... Research has shown ... to reduce the frequency and level of relapse. , At the ... and Purpose,” will explore the critical tasks of the recovery phase and beyond ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... 2016  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... quarter and year-end 2015 results after the Nasdaq market ... host a live conference call and webcast to discuss ... afternoon, February 11, 2016 at 4:30 p.m. Eastern Time ... --> http://www.neurocrine.com . --> Participants can ...
(Date:2/8/2016)... DUBLIN , Feb. 8, 2016 ... addition of the "Global Skin Protective Equipment ... --> http://www.researchandmarkets.com/research/fqx6nz/global_skin ) has announced ... Equipment Market 2016-2020" report to their offering. ... ( http://www.researchandmarkets.com/research/fqx6nz/global_skin ) has announced the addition of ...
(Date:2/8/2016)... Intarcia Therapeutics, Inc. today announced the appointment of ... created role of Vice President, Head of Global Medical ... of leadership experience at leading pharmaceutical, biotechnology, and health ... Most recently Dr. Yee served as VP, Head of ... Officer at AstraZeneca, where he led medical affairs across ...
Breaking Medicine Technology: